Simona Paglia
Overview
Explore the profile of Simona Paglia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sansone V, Auteri G, Tovoli F, Mazzoni C, Paglia S, Di Pietro C, et al.
J Ultrasound
. 2024 Jul;
27(3):715-722.
PMID: 39060716
Aims: Spleen and liver stiffness, investigated by VCTE (Vibration-Controlled Transient Elastography), have been associated with marrow fibrosis in patients with myeloproliferative neoplasms (MPNs). Tissue stiffness can be assessed by shear...
2.
Palandri F, Rossi E, Auteri G, Breccia M, Paglia S, Benevolo G, et al.
Cancers (Basel)
. 2023 Jul;
15(14).
PMID: 37509367
In polycythemia vera (PV), the prognostic relevance of an ELN-defined complete response (CR) to hydroxyurea (HU), the predictors of response, and patients' triggers for switching to ruxolitinib are uncertain. In...
3.
Auteri G, Paglia S, Mazzoni C, Biondo M, Venturi M, Romagnoli A, et al.
Mediterr J Hematol Infect Dis
. 2023 May;
15(1):e2023029.
PMID: 37180204
Background And Objectives: Several infections and vaccinations can provoke immune thrombocytopenia (ITP) onset or relapse. Information on ITP epidemiology and management during the Covid-19 pandemic is scarce. In a large...
4.
Palandri F, Elli E, Auteri G, Bonifacio M, Benevolo G, Heidel F, et al.
Blood Cancer J
. 2023 May;
13(1):65.
PMID: 37137878
No abstract available.
5.
Palandri F, Breccia M, Mazzoni C, Auteri G, Elli E, Trawinska M, et al.
Cancer
. 2023 Mar;
129(11):1704-1713.
PMID: 36932983
Background: Patients with cytopenic myelofibrosis (MF) have more limited therapeutic options and poorer prognoses compared with patients with the myeloproliferative phenotype. Aims And Methods: Prognostic correlates of cytopenic phenotype were...
6.
Auteri G, Biondo M, Mazzoni C, Venturi M, Romagnoli A, Paglia S, et al.
Heliyon
. 2023 Feb;
9(2):e13462.
PMID: 36846652
Fostamatinib is a SYK-inhibitor drug recently approved by the FDA and EMA for treating chronic immune thrombocytopenia. This drug induces a response in about 40% of patients and has a...
7.
Sollazzo M, Paglia S, Di Giacomo S, Grifoni D
Front Cell Dev Biol
. 2023 Jan;
10:1043630.
PMID: 36704198
Tumor cells exploit multiple mechanisms to evade apoptosis, hence the strategies aimed at reactivating cell death in cancer. However, recent studies are revealing that dying cells play remarkable pro-oncogenic roles....
8.
Beghelli D, Zallocco L, Barbalace M, Paglia S, Strocchi S, Cirilli I, et al.
Oxid Med Cell Longev
. 2022 Feb;
2022:1744408.
PMID: 35222791
Aging is a multifactorial phenomenon characterized by degenerative processes closely connected to oxidative damage and chronic inflammation. Recently, many studies have shown that natural bioactive compounds are useful in delaying...
9.
Paglia S, Sollazzo M, Di Giacomo S, Strocchi S, Grifoni D
Semin Cancer Biol
. 2019 May;
63:49-59.
PMID: 31102666
Cancer has long been regarded and treated as a foreign body appearing by mistake inside a living organism. However, now we know that cancer cells communicate with neighbours, thereby creating...
10.
Sollazzo M, Genchi C, Paglia S, Di Giacomo S, Pession A, de Biase D, et al.
Front Genet
. 2019 Jan;
9:612.
PMID: 30619451
The term "field cancerisation" describes the formation of tissue sub-areas highly susceptible to multifocal tumourigenesis. In the earlier stages of cancer, cells may indeed display a series of molecular alterations...